Table 5.
Summary of previous studies
| Study | n | Baseline CKD, n (%) |
|---|---|---|
| Ascione et al. (1999)11 | 50 | 0 (0) |
| Nathoe et al. (2003) | 281 | 0 (0) |
| Tang et al. (2002) | 40 | 0 (0) |
| Legare et al. (2003) | 300 | 11 (3.7) |
| Puskas et al. (2003) | 197 | 4 (2) |
| Straka et al. (2004) | 388 | 3 (0.8) |
| Khan et al. (2004) | 104 | 0 (0) |
| Gerola et al. (2004) | 160 | 0 (0) |
| Wan et al. (2004) | 37 | 0 (0) |
| Staton et al. (2005) | 197 | 0 (0) |
| Jensen et al. (2006) | 120 | 0 (0) |
| Motallebzadeh et al. (2006) | 210 | 0 (0) |
| Sajja et al. (2007)17 | 116 | 116 (100) |
| Magee et al. (2008) | 3014 | 67 (2.2) |
| Paulitsch et al. (2009) | 92 | 0 (0) |
| Shroyer et al. (2009)4 | 2203 | 173 (7.9) |
| Hueb et al. (2010) | 308 | 0 (0) |
| Moller et al. (2010) | 339 | 13 (3.8) |
| Total | 8156 | 387 (4.7) |
A complete list of references for these studies is provided in Supplemental Material.